Table of Contents

company-logo

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Gossamer Bio Dividend Announcement

• Gossamer Bio does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Gossamer Bio dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Gossamer Bio Dividend History

Gossamer Bio Dividend Yield

Gossamer Bio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Gossamer Bio stock? Use our calculator to estimate your expected dividend yield:

Gossamer Bio Financial Ratios

P/E ratio-2.21
PEG ratio0.01
P/B ratio2.92
ROE-127.28%
Payout ratio0.00%
Current ratio6.74
Quick ratio6.74
Cash Ratio0.56

Gossamer Bio Dividend FAQ

Does Gossamer Bio stock pay dividends?
Gossamer Bio does not currently pay dividends to its shareholders.
Has Gossamer Bio ever paid a dividend?
No, Gossamer Bio has no a history of paying dividends to its shareholders. Gossamer Bio is not known for its dividend payments.
Why doesn't Gossamer Bio pay dividends?
There are several potential reasons why Gossamer Bio would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Gossamer Bio ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Gossamer Bio has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Gossamer Bio a dividend aristocrat?
Gossamer Bio is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Gossamer Bio a dividend king?
Gossamer Bio is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Gossamer Bio a dividend stock?
No, Gossamer Bio is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Gossamer Bio stocks?
To buy Gossamer Bio you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Gossamer Bio stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.